Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05411796 · ClinicalTrials.gov registry record · NA

In-use Cross-over Study of Two Different Menstrual Cups

A NA study, sponsored by Procter and Gamble.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT05411796 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05411796, a NA study, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

This study evaluated the safety and tolerability of two different menstrual cups on vaginal health

Interventions

  • DEVICE Tampax menstrual cup
  • DEVICE Other menstrual cup

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2018-08-07
Est. Completion 2018-11-14
Phase NA

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT05411796

The ClinicalTrials.gov registry entry for NCT05411796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Tampax menstrual cup is the first listed.

NCT05411796 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05411796 about?

NCT05411796 is a clinical study titled "In-use Cross-over Study of Two Different Menstrual Cups". This study evaluated the safety and tolerability of two different menstrual cups on vaginal health

What is the current status of trial NCT05411796?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2018-08-07. Estimated completion is 2018-11-14.

What interventions are being tested in trial NCT05411796?

The interventions under investigation include: Tampax menstrual cup (DEVICE), Other menstrual cup (DEVICE).

Who is sponsoring clinical trial NCT05411796?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.